[hijodelsol]

Yes, that’s a possibility and currently many monoclonal antibodies are produced that way (basically all drugs ending in “-mab”). However the process is costly and current capacities are not sufficient to supply a whole population regularly with antibodies which is why we still use some older drugs for certain diseases (think MTX for rheumatoid arthritis) and reserve monoclonal antibodies for treatment-resistant cases. I hope that it’ll be possible to protect high risk HCW and ICU patients through antibodies and thereby bring down Covid’s mortality soonish but we still need to buy some time until then and work on a vaccine to protect the population long-term. Right now what we need to do is stay at home and invest in medical care and drug development but with emphasis on the staying at home part because it’s the necessary condition for everything else to work.

[felipemnoa]

Thanks for your reply. Very informative.